| Net Cash Provided by (Used in) Operating Activities |
-19.7K |
USD |
+88.6% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
19.4K |
USD |
-88.9% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500M |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
38M |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.61K |
USD |
+7.91% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
2.56M |
USD |
+31.8% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
2.56M |
USD |
+31.8% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
5.85M |
shares |
|
Q1 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100M |
shares |
|
Q1 2025 |
Q3 2025 |
| Additional Paid in Capital |
9.66M |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
5.85M |
shares |
|
Q1 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
12.7K |
USD |
+337% |
Q3 2025 |
Q1 2026 |